Amount$35M
Post-money valuation$150M
SeriesFunding Round
AnnouncedJul 12, 2000
SectorOncology, Immunology, Life Sciences
Strong
A strong, well-structured round.
Round size vs peers
Larger than the typical Funding Round round (2.3×).
Syndicate size
Healthy syndicate of 4 investors.
Insider conviction
4 existing investors re-upped — insiders doubling down.
Investor track record
Mostly newer or unproven managers.
Heuristic read of round size vs peers, syndicate size, insider conviction, and investor track record. Not investment advice.
vs. Funding Round rounds (421)
Round size distribution58th pct
smaller Funding Round roundslarger
Post-money valuation8th pct
$4Mthis round: $150M$25B
vs. Oncology, Immunology, Life Sciences (5)
Round size in sector100th pct
$12Mthis round: $35M$20M
